TinyGemsBreaks Archive - Page 66 of 124

FridayMay 19, 2023 12:36 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO Featured in Upcoming Water Tower Research Fireside Chat

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, will be represented at an upcoming Water Tower Research Fireside Chat Series. The company announced that CEO Eric A. Adams will be the featured speaker at the May 23, 2023, fireside chat; the event is slated to begin at 1 p.m. ET. During the chat, Adams will present an overview of the company’s pharmaceutical development pipeline. He will also discuss subsidiary BayMedica and its anticipated impact on InMed's growth as well as upcoming catalysts for the company. A replay of the…

ThursdayMay 18, 2023 2:46 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Study Demonstrates Significant Enhancement in Oral Estradiol Delivery

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced successful completion of its animal study HOR-A22-1, showing significant enhancement in the oral delivery of the estrogen hormone estradiol, an important component of therapeutic products in the women’s health sector. According to the update, the DehydraTECH-estradiol formulation achieved an average peak concentration in the bloodstream (or “Cmax”) of 5.65ng/mL, roughly nine times (900%) higher than that achieved with the control formulation at only 0.63 ng/mL. In addition, with estradiol known to be quickly converted into the metabolite estrone by cells in the uterus, mammary glands and…

ThursdayMay 18, 2023 11:43 am

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports that Common Stock Has Met NASDAQ $1 Minimum Bid Price Requirement

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has reported that its stock has traded above NASDAQ’s $1 minimum bid price requirement for 10 consecutive days, a key guideline to meet NASDAQ trading requirements. In September 2022, the company was notified by NASDAQ that its common stock no longer met the minimum $1 bid price per share requirement. Consequently, the company was given 180 calendar days to regain compliance; that deadline was extended another 180 days earlier this year. In an effort to meet the requirement, Mullen implemented a reverse stock split, effective May 4, 2023. As a…

ThursdayMay 18, 2023 10:42 am

TinyGemsBreaks – RYVYL Inc. (NASDAQ: RVYL) Plans to Report on Q1 2023 Earnings Next Week

RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, has announced that it will release its first-quarter financial results on Monday, May 22, 2023. The company will also host an earnings webinar on that same day, beginning at 4:30 p.m. During the webinar, key executives will discuss the earnings results and answer questions. Those interested in accessing that event may dial 1-855-327-6837 in the United States or 1-631-891-4304 internationally. A recording of the call will also be available. Those interested in listening to that can dial 1-844-512-2921 within…

WednesdayMay 17, 2023 12:47 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Signs New Contract with Texas Semiconductor Company

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has received a new contract for three K5 ASRs from a semiconductor company in Texas. The new contract is the latest in a series of contracts Knightscope has announced as the company works to provide key services to protect vital industries. According to the announcement, the semiconductor market reportedly totaled $600 billion in sales in 2021 and is projected to reach $1 trillion within this decade. “Semiconductors are the heart of contemporary electronics, enabling technologies that are essential to U.S. economic growth, national…

WednesdayMay 17, 2023 11:25 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN), NRTC Commence Class 3 Assembly Line Installation and Integration

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that vehicle production will begin in July 2023 at Mullen’s Manufacturing Center in Tunica, Mississippi. According to the announcement, Mullen’s manufacturing group is collaborating with NRTC Automation (“NRTC”) out of Birmingham, Alabama, for Class 3 assembly line installation and integration, including all robotics and automation systems for vehicle production. NRTC will support Mullen’s Class 3 operation through launch and provide ongoing support of the production as Mullen ramps up to meet the full market demand from its commercial customers. “It’s gratifying to see our Class 3 vehicle production…

TuesdayMay 16, 2023 2:39 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Provides Transcript and Video of Yesterday’s Q1 Town Hall Update

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today released the transcript and video of its First Quarter Town Hall Update that occurred at 1 p.m. PT on May 15, 2023. In the update, the company’s CEO William Santana Li reviewed financial highlights from Knightscope’s recently filed quarterly report on Form 10-Q for the first quarter 2023, as well as shared current events that may be of interest to stockholders and potential investors. “First, I am pleased to report that for the 1st quarter of 2023, we recorded approximately $2.9M in revenue…

MondayMay 15, 2023 3:30 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results, Provides Business Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced financial results for the third quarter of the fiscal year 2023, which ended March 31, 2023. “The third quarter of fiscal year 2023 was an important period for InMed, as we achieved several key milestones across our different business segments, including completing enrollment in our phase 2 clinical trial for epidermolysis bullosa, marking the first time cannabinol (‘CBN’) has completed a phase 2 clinical trial. We look forward to the data read out during 3Q and will then…

MondayMay 15, 2023 3:13 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Lands $1.25M Contract with Rutgers University

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announced its receipt of a $1.25 million contract for its K1 Blue Light Towers and K1 E-Phones. The State University of New Jersey (“Rutgers”) signed purchase orders for a total of 145 devices. The announcement reads, “Rutgers stands among America’s highest-ranked, most diverse public research universities and is the oldest, largest and top-ranked public university in the New York/New Jersey metropolitan area. It has been using Knightscope’s emergency communication devices since 2022 and has been slowly expanding its footprint of the familiar blue…

MondayMay 15, 2023 2:24 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q1 2023 Results, Corporate Update

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced its financial results for the quarter ended March 31, 2023. In addition, the company provided a clinical update of its anti-cancer drug candidate currently in development for the treatment of primary and metastatic brain and CNS cancer. “Over the course of the first quarter, our team has continued its flawless operational execution of our potentially pivotal study witnessed by our recent enrollment update boasting 100 patients now dosed in this global clinical…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks